Lucid Diagnostics Inc. (ticker: LUCD) is an NASDAQ-listed surgical & medical instruments & apparatus company. DredgeCap's structured extraction of LUCD's SEC filings surfaces 2 active risk signals, including 1 auditor-change signal, and 1 late-filing signal. LUCD reported $3.20M in revenue and -$13.91M for the period ending 2025-09-30, with operating cash flow of -$12.10M. Cash and equivalents stood at $47.33M (up 226.7% year-over-year). Total assets of $34.08M exceed total liabilities of $30.08M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
LUCD SEC Filings
Full cached SEC EDGAR filing history for LUCD, grouped by form type and sorted newest-first within each group. 0 filings across 0 form types.
Filings sourced verbatim from SEC EDGAR submissions metadata. “Structured” links route to DredgeCap's per-filing renderer (XBRL-backed financials + cited highlights) when available; the EDGAR link always points to the canonical accession index on sec.gov.